Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3138 |
|
| Actual shortage: | 252 (8%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2876 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
18 (7%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125455 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181594 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-10-05 | 2024-08-27 | 206389 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-11-09 | 2024-05-09 | 209675 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2024-02-22 | 2024-05-09 | 220264 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2024-03-07 | 2024-08-27 | 221549 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2021-06-24 | 2021-07-09 | 141460 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2021-07-29 | 2021-08-13 | 143246 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-06-03 | 2022-07-20 | 161931 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176833 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179194 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2020-08-13 | 2020-10-22 | 122211 |
| TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
| TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Actual shortage | 2025-08-29 | 2025-10-30 | 266199 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2018-09-12 | 2019-03-12 | 61343 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2020-01-09 | 2020-08-21 | 102931 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119883 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124956 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-TOPILENE | 0.05% | LOTION | Discontinued | 2025-05-28 | 2025-05-28 | 258553 |